A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
Clinical trial NCT06294548 · RECRUITING
Trial details
- NCT number
- NCT06294548
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-29
- Primary completion
- 2028-01-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.